Previously, we demonstrated that elevated ATF4 action during T2D downregulated incretin receptors’ Gs/cAMP signaling via PDE4D without altering Gq signaling (Lee et al., 2023). This evidence concerns the gene ATF4 and type 2 diabetes mellitus.